학술논문
Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non–Small Cell Lung Cancers
Document Type
Article
Author
Source
In Journal of Thoracic Oncology October 2017 12(10):1496-1502
Subject
Language
ISSN
1556-0864